Eagle Genomics Raises USD20M First Close of Funding

Eagle Genomics, a Cambridge, England, UK-based TechBio platform business applying network science to biology, raised a USD 20 million first close of its scale-up funding round. The round is being led by abrdn plc, with continued participation from existing investors Environmental Technologies Fund, and a consortium of investors headed by Granpool Innovative Investments. The investment will support further development of the e[datascientist]™ platform and will continue to drive expansion into global markets and the deepening of client impact.

Eagle Genomics Secures $20 Million in Funding Led by abrdn plc

Eagle Genomics is a UK-based TechBio platform business applying network science to biology, providing the AI-augmented knowledge discovery platform, e[datascientist]™, which empowers scientists to exploit multi-dimensional data to conduct science-led innovation for next-generation products. It supports the entire innovation workflow – from hypothesis through insight to product claims – helping bring novel, safer and sustainable products to market, faster, across the Food and Nutrition, Beauty and Personal Care, AgBio and BioPharma industries. The system is powered by network science and multilayer hypergraphs, applying machine learning and AI to provide a data-driven insight journey into solving complex problems at scale. It integrates active learning at every step of the microbiome innovation journey, from ‘descriptive’ to ‘predictive,’ while identifying mechanisms of action.

Eagle Genomics is a UK-based TechBio platform business applying network science to biology, providing the AI-augmented knowledge discovery platform, e[datascientist]™, which empowers scientists to exploit multi-dimensional data to conduct science-led innovation for next-generation products.

3 years ago

Eagle Genomics Secures $20 Million in Funding Led by abrdn plc

ProblemTechnology

Solution

Covered on